A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival-Reference-Cited by-同舟云学术

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

Published:2003-10 Issue:5 Volume:12 Page:320-327
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Ogston Keith N,Miller Iain D,Payne Simon,Hutcheon Andrew W,Sarkar Tarun K,Smith Ian,Schofield A,Heys Steven D

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference21 articles.

1. Rubens R D. The management of locally advanced breast cancer. Br J Cancer 1992; 65: 145–147.

2. Obscenely S, Tubiana M, Le M G. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 1984; 49: 709–715.

3. Fisher B, Brown A, Mamounas E et al. Effect of pre-operative chemotherapy on the outcome in women with operable breast cancer. J Clin Oncol 1998; 16: 2672–2685.

4. Ragaz J, Baird R, Rebbeck P et al. Pre-operative versus post-operative chemotherapy for stage (I-II) breast cancer: long term analysis of British Colombia randomized trial. Proc Am Soc Clin Oncol 1997; 16: 142a.

5. Mauriac L, MacGrogan G, Avril A et al. Neoadjuvant chemotherapy for breast cancers larger than 3cms. A unicentre randomised trail with a 124 month follow up. Ann Oncol 1999; 10: 47–52.

Cited by 770 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapy;The Breast;2024-12

2. Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial;Radiotherapy and Oncology;2024-11

3. Predicting efficacy of neoadjuvant chemotherapy in breast cancer patients with synthetic magnetic resonance imaging method MAGiC: An observational cohort study;European Journal of Radiology;2024-10

4. Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer;JAMA Oncology;2024-09-12

5. Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer;npj Precision Oncology;2024-09-05